Kivrak, M. Et Al. 2025. Exploring the Therapeutic Potential of the DOT1L Inhibitor EPZ004777 Using Bioinformatics and Molecular Docking Approaches in Acute Myeloid Leukemia. CURRENT ISSUES IN MOLECULAR BIOLOGY , vol.47, no.3 , 1-23.

Kivrak, M., Nalkiran, İ., & Sevim Nalkiran, H., (2025). Exploring the Therapeutic Potential of the DOT1L Inhibitor EPZ004777 Using Bioinformatics and Molecular Docking Approaches in Acute Myeloid Leukemia. CURRENT ISSUES IN MOLECULAR BIOLOGY , vol.47, no.3, 1-23.

Kivrak, MEHMET, İHSAN NALKIRAN, And HATİCE SEVİM NALKIRAN. "Exploring the Therapeutic Potential of the DOT1L Inhibitor EPZ004777 Using Bioinformatics and Molecular Docking Approaches in Acute Myeloid Leukemia," CURRENT ISSUES IN MOLECULAR BIOLOGY , vol.47, no.3, 1-23, 2025

Kivrak, MEHMET Et Al. "Exploring the Therapeutic Potential of the DOT1L Inhibitor EPZ004777 Using Bioinformatics and Molecular Docking Approaches in Acute Myeloid Leukemia." CURRENT ISSUES IN MOLECULAR BIOLOGY , vol.47, no.3, pp.1-23, 2025

Kivrak, M. Nalkiran, İ. And Sevim Nalkiran, H. (2025) . "Exploring the Therapeutic Potential of the DOT1L Inhibitor EPZ004777 Using Bioinformatics and Molecular Docking Approaches in Acute Myeloid Leukemia." CURRENT ISSUES IN MOLECULAR BIOLOGY , vol.47, no.3, pp.1-23.

@article{article, author={MEHMET KIVRAK Et Al. }, title={Exploring the Therapeutic Potential of the DOT1L Inhibitor EPZ004777 Using Bioinformatics and Molecular Docking Approaches in Acute Myeloid Leukemia}, journal={CURRENT ISSUES IN MOLECULAR BIOLOGY}, year=2025, pages={1-23} }